article thumbnail

Benefits of 3D printing for personalised medicine formulation

European Pharmaceutical Review

The authors aimed to evaluate and compare the efficacy and acceptability of chewable 3D printed medicines containing citrulline, isoleucine, and valine alone or in combination. Administration is challenging and preparation of these formulations via pharmaceutical compounding is “time-consuming”, the paper highlighted.

article thumbnail

Stakeholder Mapping for Pharmaceutical Products

Celeritas

Stakeholder Mapping involves identifying professionals in the target therapeutic field who would utilize or influence the utilization of the pharmaceutical product. Contacting stakeholders can be key to knowing where they stand upon the release of the pharmaceutical product. Complicated patient cases are attended by them.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Securing every dose with an edible security technology for safe medicines

European Pharmaceutical Review

FAKE MEDICINES are not a new problem, and pose a tremendous threat to patient safety and public health in society regardless of a country’s economic status. 1 Simply, pharmaceutical products are the most vulnerable to counterfeiting. 1 Simply, pharmaceutical products are the most vulnerable to counterfeiting.

article thumbnail

Fosun Pharma and IFC to build new drug manufacturing plant in Africa

Pharmaceutical Technology

Shanghai Fosun Pharmaceutical (Group) is to collaborate with the International Finance Corporation (IFC) to construct a new pharmaceutical production facility and distribution hub near Abidjan, Côte d’Ivoire. Its estimated production capacity on completion is five billion tablets per year.

article thumbnail

Elite 2024 Disrupter Bryan Johnson of Veeva Systems

PM360

During his college years at Bentley University, Bryan’s internships at Covidien (Medtronic) and Cubist (Merck) sparked a love for analytics and operations that could help bring the right treatment to patients. After completing his MBA, he joined Veeva, a cloud software company for life sciences, as the senior director of product management.

Retail 52
article thumbnail

AbbVie sucks

World of DTC Marketing

market until next year, with the pharmaceutical company announcing Tuesday a settlement with the Iceland-based Alvotech. billion last year, the highest total for any pharmaceutical product and they will do anything to keep that money. AbbVie significantly inflated prices over the past two decades for patients in the U.S.

article thumbnail

Camrelizumab by Jiangsu Hengrui Medicine for Solid Tumor: Likelihood of Approval

Pharmaceutical Technology

Camrelizumab is under clinical development by Jiangsu Hengrui Medicine and currently in Phase I for Solid Tumor. Jiangsu Hengrui Medicine overview Jiangsu Hengrui Medicine (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture, and distribution of novel pharmaceutical products.